Age, Biography and Wiki

Aimée R. Kreimer (Aimée Rebecca Kreimer) was born on 19 August, 1975 in Washington, D.C., U.S., is an American cancer epidemiologist. Discover Aimée R. Kreimer's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is she in this year and how she spends money? Also learn how she earned most of networth at the age of 48 years old?

Popular As Aimée Rebecca Kreimer
Occupation N/A
Age 48 years old
Zodiac Sign Leo
Born 19 August 1975
Birthday 19 August
Birthplace Washington, D.C., U.S.
Nationality United States

We recommend you to check the complete list of Famous People born on 19 August. She is a member of famous with the age 48 years old group.

Aimée R. Kreimer Height, Weight & Measurements

At 48 years old, Aimée R. Kreimer height not available right now. We will update Aimée R. Kreimer's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.

Physical Status
Height Not Available
Weight Not Available
Body Measurements Not Available
Eye Color Not Available
Hair Color Not Available

Dating & Relationship status

She is currently single. She is not dating anyone. We don't have much information about She's past relationship and any previous engaged. According to our Database, She has no children.

Family
Parents Not Available
Husband Not Available
Sibling Not Available
Children Not Available

Aimée R. Kreimer Net Worth

Her net worth has been growing significantly in 2023-2024. So, how much is Aimée R. Kreimer worth at the age of 48 years old? Aimée R. Kreimer’s income source is mostly from being a successful . She is from United States. We have estimated Aimée R. Kreimer's net worth, money, salary, income, and assets.

Net Worth in 2024 $1 Million - $5 Million
Salary in 2024 Under Review
Net Worth in 2023 Pending
Salary in 2023 Under Review
House Not Available
Cars Not Available
Source of Income

Aimée R. Kreimer Social Network

Instagram
Linkedin
Twitter
Facebook
Wikipedia
Imdb

Timeline

1975

Aimée Rebecca Kreimer (born August 19, 1975) is an American cancer epidemiologist who researches the etiology and prevention of human papillomavirus infection (HPV) and cancer prevention.

She is a senior investigator in the infections and immunoepidemiology branch at the National Cancer Institute.

Kreimer was born August 19, 1975, in Washington, D.C. She completed a B.S. in Animal Science with a minor in Biology and a concentration in pre-veterinary medicine at the University of Delaware in May 1997.

1998

Kreimer earned a M.S. from the department of health evaluation sciences, division of biostatistics and epidemiology at the University of Virginia in May 1998.

Her thesis was titled, Evaluation of the Effectiveness of Treatment with Cortisol in Physiologic Doses in Patients with Naturally Acquired Influenza A.

Kreimer received a Ph.D. in infectious disease epidemiology from the Johns Hopkins Bloomberg School of Public Health.

2003

Her 2003 dissertation was titled, The descriptive epidemiology of oral human papilloma virus (HPV) infection: associations with high-risk sexual behaviors and HPV serostatus.

Anthony J. Alberg was her doctoral advisor and Maura L. Gillison was her mentor.

Kreimer conducted postdoctoral research at the International Agency for Research on Cancer and the National Cancer Institute (NCI).

Kreimer is a senior investigator in the NCI infections and immunoepidemiology branch (IIB).

She studies the etiology and prevention of human papillomavirus (HPV) and cancers at multiple sites, including the head and neck and anogenital region, with a particular focus on translational research and cancer prevention.

2018

In 2018, she received the National Institutes of Health (NIH) Director's Award in the category of Science/Medicine for her outstanding achievements in HPV cancer research and leadership in the Costa Rica HPV Vaccine Trial.

In 2021, she was elected by her peers to serve a three-year term as NCI division of cancer epidemiology and genetics (DCEG) Woman Scientific Advisor, and elected to the executive board of the International Papillomavirus Society.